AlphaCentric Advisors »

Global Med Reit shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Global Med Reit (XRN) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Global Med Reit

Tip: Access up to 7 years of quarterly data

All positions including Global Med Reit held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global Med Reit by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $188k 5.0k 37.52

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Vertex Pharmaceuticals Incorporated (VRTX)
Invitation Homes (INVH)
Astrazeneca Ord (AZN)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Axsome Therapeutics (AXSM)
Apogee Therapeutics (APGE)
Euronet Worldwide (EEFT)
Aeva Technologies Com New (AEVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for AlphaCentric Advisors

Top funds holding Global Med Reit

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Heartland Advisors
Alyeska Investment Group
Geode Capital Management
State Street Corporation
Invesco
Stifel Financial
Uniplan Investment Counsel
Bank of New York Mellon
Dimensional Fund Advisors
Cutler Capital Management
Peregrine Capital Management
Susquehanna International

View all funds holding Global Med Reit